‹ News

BLBX FSM GLW INNV NCI EQX RAIL FN VKTX AU

INNV: Ascending Triangle detected on 24 Feb 2026

Overall Score

84 of 100

Strong

Win Probability

75%

High

Reward / Risk

2.4 : 1

$0.19 reward $-0.08 risk

Summary Context Technical Indicators

Current Setup

InnovAge is forming an ascending triangle pattern following a strong bull flag that formed January 13 with 32.6 pattern quality and a three-white-soldiers bullish continuation on February 19. At $8.92, the stock trades between key support at $7.78 and resistance at $9.18, with a structure score of 15.0 and breakout score of 13.0. The overall pattern scores 83.7 with 75.28% win probability. Volume ratio of 1.2x and relative volume of 1.21x confirm institutional interest. The pattern sits 243% above its 52-week low, reflecting the 50% monthly gain momentum.

Stock Context

InnovAge reported February Q2 results showing revenue of $239.7 million (up 14.7% YoY) with net income returning to $10.6 million, and raised fiscal 2026 revenue guidance to $925–950 million. The company achieved a 9.2% adjusted EBITDA margin, meeting its 8–9% intermediate-term target for the first time, and successfully reinstated Medicaid coverage driving stronger-than-expected census growth. In January 2026, the company appointed Pavithra Mahesh from Apax Partners and Sean Traynor to the Board, signaling private equity confidence in the PACE scaling platform. The earnings beat and guidance raise are driving this breakout—the market is repricing profitability recovery after years of losses.

What to Expect

The ascending triangle setup targets $9.37 on a measured-move basis, a modest 5% move from current $8.92 levels. For this setup to confirm, INNV needs a breakout above $9.18 resistance on sustained volume above 376K shares (20-day average); the 1.21x relative volume reading already shows conviction. Historical data shows ascending triangles with 75.28% win probability deliver predictable follow-through. Invalidation occurs below $7.78 support, where the pattern structure collapses and prior support becomes a breach point. Given the sector regime is bullish and the stock already gained 50% in one month, the pattern suggests consolidation ahead of the next thrust.

Risk Factors

The RSI at 70.75 signals overbought conditions—momentum extremes often precede pullbacks. Management warned Q3 will be softer due to slower enrollment following open enrollment and severe flu season impact, plus the company faces 6% annualized voluntary disenrollment and $4.7 million in de novo center losses from Tampa and Orlando operations. Analyst consensus price target remains just $5.00, with no buy ratings and one sell, implying 42.7% downside risk from current levels. Participant retention remains a structural challenge. Beta of 0.57 provides downside cushion but limits upside acceleration. The 1.50% 20-day volatility and elevated price action create gap risk if guidance falters.

Market & Sector Regime

Market

Neutral 0.00

-1.0 0 +1.0

Health Care Sector

Bullish 0.00

-1.0 0 +1.0

Other Patterns Detected Today

Bull Flag

27 days in pattern

Very Strong 32.6

Three White Soldiers

3 days in pattern

Strong 25.0

Overall Score

38 of 40

Exceptional

Pattern Quality

20 of 20

Exceptional

Setup

13 of 20

Moderate

R/R

12 of 18

Moderate

Context

Pattern Quality Score

15 of 15

Exceptional

Structure

13 of 13

Exceptional

Breakout

10 of 12

Strong

Volume

Recent Performance

+6.7%

+50.2%

+77.3%

Momentum & Trend

RSI (14)

70.8

Overbought

MACD Histogram

+0.05

Bullish

Bollinger Band Position

80.4%

Upper Zone

Volatility & Risk

20-Day Volatility

1.50

Very High

ATR %

8.9%

High

Beta

0.57

Below Mkt

Volume Analysis

Volume Ratio

1.20x

Above Avg

20-Day Avg Vol

376K

shares / day

Current Volume

453K

shares traded

Price Levels

Target

$9.37

52W High

$9.19

Resistance

$9.18

Current

$8.92

Stop Loss

$8.11

Support

$7.78

52W Low

$2.60

Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.